Learn more about whether Corcept Therapeutics Incorporated or Zoetis Inc. is a better investment based on AAII's A+ Investor ...

Learn more about whether Corcept Therapeutics Incorporated or Haleon plc is a better investment based on AAII's A+ Investor ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...

From redefining precision surgery to advancing non-opioid pain treatments, this year’s winners of the Chancellor’s Innovation ...

For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, ...

Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain (“CINP”) Phase 2b Trial -- ...

Virtual reality (VR) might be able to provide cancer patients significant pain relief, a new study says. A small group of ...

Common treatments may not be as effective for women as they are for men, mouse model reveals In a nutshell Research reveals ...

ATLANTA - Dogwood Therapeutics, Inc. (NASDAQ:DWTX), a biopharmaceutical company specializing in non-opioid pain treatments, has announced the initiation of a Phase 2b clinical trial for Halneuron®, ...

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2024 Earnings Call Transcript March 17, 2025 Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were ...

ATLANTA - Dogwood Therapeutics, Inc. (NASDAQ:DWTX), a biopharmaceutical company specializing in non-opioid pain treatments, has announced the initiation of a Phase 2b clinical trial for Halneuron ...

ATLANTA, March 18, 2025 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical ...